EZH2 and lymphoma: EZH2 depletion or pharmacological inhibition in GC-derived lymphoma cells also induced a profound anti-proliferative effect, and this was accompanied by more substantial derepression of CDKN1A (p21Cip1) than other cyclin-dependent kinase inhibitor genes6, 7.